Table 1

Individual, Practice, and Residency Characteristics by Preparedness and Current Practice of Buprenorphine Treatment

CharacteristicsPreparedPracticing
YesNoPYesNoP
No. (%)No. (%)ValueNo. (%)No. (%)Value
Individual characteristics
Prepared to provide buprenorphinea
 Yes63 (45.7)135 (7.3)<.01
 No75 (54.3)1,706 (92.7)
Sex
 Male81 (40.9)785 (44.1).9567 (48.5)799 (43.4).10
 Female117 (59.1)996 (55.9)71 (51.5)1,042 (56.6)
Age36.4 (4.4)35.9 (4.4).1636.1 (4.5)35.9 (4.4).38
Medical school type
 Allopathic180 (90.9)1,508 (84.7).09125 (90.6)1,563 (84.9).18
 Osteopathic18 (9.1)273 (15.3)13 (9.4)278 (15.1)
Loan program
 Yes75 (37.9)609 (34.2).9453 (38.4)631 (34.3).49
 No123 (62.1)1,172 (65.8)85 (61.6)1,210 (65.7)
Researchb
 Yes38 (19.2)241 (13.5).0236 (26.1)243 (13.2)<.01
 No160 (80.8)1,540 (86.5)102 (73.9)1,598 (86.8)
Faculty
 Yes23 (11.6)212 (11.9).9823 (16.7)212 (11.5).17
 No175 (88.4)1,569 (88.1)115 (83.3)1,629 (88.5)
Residency characteristics
FQHC
 Yes49 (25.5)313 (19.0).2535 (25.9)327 (19.1).14
 No143 (74.5)1,339 (81.0)100 (74.1)1,382 (80.9)
THC funding
 Yes9 (4.6)66 (3.7).7011 (8.0)64 (3.5).06
 No189 (95.4)1,715 (96.3)127 (92.0)1,777 (96.5)
Rural track
 Yes19 (9.6)142 (8.0).889 (6.5)152 (8.3).45
 No179 (90.4)1,639 (92.0)129 (93.5)1,689 (91.7)
Residency region
 Northeast65 (32.8)278 (15.6).0133 (23.9)310 (16.8).01
 South42 (21.2)600 (33.7)35 (25.4)607 (33.0)
 Midwest41 (20.7)530 (29.8)26 (18.8)545 (29.6)
 West50 (25.3)373 (20.9)44 (31.9)379 (20.6)
Residents per class9.4 (3.2)8.5 (2.9).068.9 (2.7)8.5 (3.0).38
Practice characteristics
FQHC
 Yes32 (26.7)156 (10.2).01
 No88 (73.3)1,374 (89.8)
Rural
 Yes3 (2.5)68 (4.4).44
 No117 (97.5)1,462 (95.6)
Site size
 Solo practice8 (6.7)50 (3.3).10
 2-5 physicians34 (28.3)575 (37.6)
 6-20 physicians49 (40.8)567 (37.0)
 >20 physicians29 (24.2)338 (22.1)
Site region
 Northeast32 (23.4)215 (12.0)<.01
 South34 (24.8)646 (36.0)
 Midwest19 (13.9)442 (24.6)
 West52 (37.9)491 (27.4)
  • FQHC = federally qualified health center; THC = Teaching Health Center.

  • a Preparedness is self-reported as prepared in residency to provide buprenorphine treatment.

  • b Research is self-reported as engagement in research or practice-based research network activities.